DCTH (Delcath Systems) Interest Expense: $0.00 Mil (TTM As of Mar. 2026)

What is Delcath Systems Interest Expense?

Delcath Systems DCTH +2.25% 70 Interest Expense is $0.00 Mil as of Mar. 2026. GuruFocus rates DCTH with a GF Score™ of 70/100 and a GF Value™ of $36.90 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Delcath Systems's interest expense for the three months ended in Mar. 2026 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Delcath Systems's Operating Income for the three months ended in Mar. 2026 was $ -1.64 Mil. Delcath Systems's Interest Expense for the three months ended in Mar. 2026 was $ 0.00 Mil. GuruFocus does not calculate Delcath Systems's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Delcath Systems (NAS:DCTH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Delcath Systems's Interest Expense for the three months ended in Mar. 2026 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-1.64 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $0.82 Mil.

Delcath Systems's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

GuruFocus does not calculate Delcath Systems's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Delcath Systems Inc has enough cash to cover all of its debt. Its financial situation is stable.

Delcath Systems Interest Expense Historical Data

* Premium members only.

The historical data trend for Delcath Systems's Interest Expense can be seen below:

Delcath Systems Interest Expense Chart

Delcath Systems Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-1.19

-2.69

-1.44

0.00

Delcath Systems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

70GF Score

Delcath Systems Inc DCTH

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Delcath Systems Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $0.00 Mil mean?

Delcath Systems (DCTH) has a Interest Expense of $0.00 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Delcath Systems and its competitors.

Is Delcath Systems' Interest Expense too high?

Delcath Systems' current Interest Expense is $0.00 Mil. Overall, Delcath Systems has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Delcath Systems' Interest Expense compare to VMD and VREX?

Delcath Systems' Interest Expense of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Delcath Systems and its competitors. Delcath Systems's current Interest Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Delcath Systems stock overvalued right now?

Based on GuruFocus' analysis, Delcath Systems (DCTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $36.90, compared to a current price of $13.20 — trading 64.2% below its estimated fair value. The current Interest Expense is $0.00 Mil. Delcath Systems' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Delcath Systems (DCTH), the current Interest Expense is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delcath Systems (DCTH) Overvalued in 2026?

Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued. The current stock price of $13.20 is trading 64.2% below its estimated GF Value™ of $36.90. GuruFocus considers Delcath Systems to be Significantly Undervalued.

Key valuation signals for DCTH:

Interest Expense: $0.00 Mil
GF Value™: $36.90 vs. price of $13.20 (64.2% below fair value)
GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Delcath Systems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies VMD VREX SI MOBI OFIX PACB KIDS CV CATX ELMD ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges DV3R:Germany

Address 566 Queensbury Avenue, Queensbury, NY, USA, 12804

Website https://www.delcath.com

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

70GF Score

Get the complete analysis for DCTH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.20

Price

$36.90

GF Value

View DCTH Analysis

See Interest Expense data for all stocks →